ArticleFrontiers in nutrition2024
Prognostic value of the Naples Prognostic Score in adult chronic obstructive pulmonary disease: NHANES 2005-2018.
Article in Frontiers in nutrition, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Association Between Naples Prognostic Score and All-Cause Mortality in Individuals with Cardio-Renal-Metabolic Multimorbidity: A Cohort Study.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2026Article
- Comparison of Tools for Nutrition Assessment in Stable Subjects with Chronic Obstructive Pulmonary Disease: Which is the Best Mortality Predictor in Real Clinical Practice?International journal of chronic obstructive pulmonary disease · 2026Observational
- Prognostic nutritional index, Naples prognostic score and Osaka prognostic score as predictors of acute respiratory distress syndrome in non-diabetes mellitus patients with sepsis: a loss of predictive efficacy of NPS and OPS in diabetes mellitus cohorts.Frontiers in endocrinology · 2026Article
- Associations between naples prognostic score and stroke and mortality among older adults.European journal of medical research · 2025Article
- The Naples prognostic score as a nutritional and inflammatory biomarkers of stroke prevalence and all-cause mortality: insights from NHANES.Journal of health, population, and nutrition · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Previous studies have demonstrated that the Naples Prognostic Score (NPS) provides strategic direction in the prognosis of malignant illness. Nevertheless, its relationship with chronic obstructive pulmonary disease (COPD) remains underexplored. Therefore, additional research specifically focusing on the relationship between the Naples Prognostic Score and COPD is necessary to determine its widespread applicability. Objectives: The objective was to explore the relationship between the NPS and the susceptibility to developing COPD. Methods: A total of 15,184 participants were included in our research, and statistical analyses were performed after weighting. We used weighted logistic regression to assess whether the NPS and COPD had a relationship, as well as its association with lung function. Subgroup analysis was used to detect the interaction. In addition, Kaplan-Meier survival curves were generated, and adjusted hazard ratios of different causes of death were calculated using Cox regression. Results: Our investigation examined 15,184 participants' data and then revealed a significant positive link between the NPS and COPD risk, while smoking has an interactive effect on it. A trend toward a decreasing prevalence of lung function indicators such as FEV1 [OR (95%CI), -339.70 (-456.53, -222.87)], FVC [OR (95%CI), -296.70 (-435.34, -158.06)], FEV1/FVC [OR (95%CI), -0.03 (-0.04, -0.02)], predicted FEV1 [OR (95%CI), -0.09 (-0.14, -0.04)], and predicted FVC [OR (95%CI), -0.08 (-0.15, -0.01)] was observed with increased NPS levels. Survival curves were drawn, and Cox regression analysis was conducted by dividing participants into group 0, group 1, and group 2 with NPS values of 0, 1-2, and 3-4, respectively. After assigning participants to groups 0, 1, and 2, with NPS values of 0, 1-2, and 3-4, respectively, the survival curves were created, and the Cox regression analysis was carried out. All-cause mortality [HR (95%CI), 1.68 (1.39-2.85)] and hypertension-related mortality [HR (95%CI), 67.64 (8.88-515.07)] of group 2 were significantly elevated. Conclusion: The findings of this study suggested that the NPS serves as a robust prognostic indicator of COPD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.